Literature DB >> 25824105

Clinical analysis of 1629 newly diagnosed malignant lymphomas in current residents of Sichuan province, China.

Xue-Mei Wang1, Bryan A Bassig2, Jing-Jing Wen1, Gan-di Li1, Zhi-Bin Liu1, Wen-Xiu Yao3, Wei Hu2, Ying Wang3, Ji-Man Li3, Xiao-Dong Wang4, Mao-Zhou Gan4, Chun-Sen Wang4, Gang Xu4, Nathaniel Rothman2, Qing Lan2, Cai-Gang Xu1.   

Abstract

Previous studies in other provinces of China (Beijing, Xinjiang, Shanxi, Jiangxi, Shanghai, Guangdong, and Taiwan) suggest that the distributions of lymphoma subtypes differ compared with Western populations. In order to evaluate the characteristics of malignant lymphoma in Sichuan, China, we analyzed case series data from incident lymphoma patients diagnosed in 2008 from three hospitals, including a total of 1629 cases and including only current residents of Sichuan. The median age of diagnosis for cases was 54 years, with a higher proportion of male cases compared with female cases. The most commonly diagnosed subtypes included diffuse large B-cell lymphoma (40.4%), NK/T-cell lymphoma (NKTCL; 11.8%), mixed cellularity Hodgkin lymphoma (7.0%), mantle cell lymphoma (4.8%), and marginal zone B-cell lymphoma (3.9%). Differences in demographic characteristics between Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) cases were apparent for median age at diagnosis (HL: 34 years; NHL: 57 years), and NHLs accounted for nearly all (99.3%) of the 931 cases of extranodal lymphoma. These findings indicate a higher proportion of NKTCL cases and a lower proportion of follicular lymphoma cases (2.3%) in these hospitals in Sichuan, relative to reports from some other provinces within China (e.g., Shanghai and Shanxi) and the USA.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  China; descriptive epidemiology; geographical variation; lymphoma

Mesh:

Year:  2015        PMID: 25824105      PMCID: PMC6760855          DOI: 10.1002/hon.2202

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  4 in total

1.  A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.

Authors:  Rong Liang; Guang-Xun Gao; Jie-Ping Chen; Ji-Shi Wang; Xiao-Min Wang; Yun Zeng; Qing-Xian Bai; Tao Zhang; Lan Yang; Bao-Xia Dong; Hong-Tao Gu; Mi-Mi Shu; Cai-Xia Hao; Jian-Hong Wang; Na Zhang; Xie-Qun Chen
Journal:  Hematol Oncol       Date:  2016-10-10       Impact factor: 5.271

2.  Epidemiologic characteristics of malignant lymphoma in Hubei, China: A single-center 5-year retrospective study.

Authors:  Jingshu Meng; Chan Chang; Huaxiong Pan; Fang Zhu; Yin Xiao; Tao Liu; Xiu Nie; Gang Wu; Liling Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

3.  Association of MDR1 C1236T Polymorphisms and B Cell Non-Hodgkin Lymphoma.

Authors:  Wei Zhang; Qun Zhang; Hui Liang; SuLi Wang; Jing Pan; ShaoYing Pan; Bin Zhu; ZhiYong Ding; WenLi Zhao; Ying Ni
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

4.  Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen.

Authors:  Wanchun Wu; Kexin Ren; Na Li; Qian Luo; Caigang Xu; Liqun Zou
Journal:  Transl Oncol       Date:  2022-04-27       Impact factor: 4.803

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.